Chitosan-based drug nanocarriers: Where do we stand?

Chitosan-based nanocarriers have become one of the most intensively studied transmucosal nanometric drug delivery platforms. This is due to a number of factors, including their simple and mild preparation technique as well as their capacity to associate macromolecules and facilitate their transport...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of controlled release 2012-07, Vol.161 (2), p.496-504
Hauptverfasser:	Garcia-Fuentes, Marcos, Alonso, Maria J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Mucosal Animals Chitosan Chitosan - therapeutic use Chitosan - toxicity Controlled release Drug Carriers - therapeutic use Drug Carriers - toxicity Drug delivery drugs Gene therapy Gene Transfer Techniques Humans Macromolecules Mucosa Nanocarriers Nanoparticles - therapeutic use Nanoparticles - toxicity Peptide and protein delivery Vaccination Vaccine delivery Vaccines - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!